Assoc Director, CRM Product Owner at Alnylam Pharmaceuticals | Cambridge, MA | $172K/yr – $233K/yr

Alnylam Pharmaceuticals

Assoc Director, CRM Product Owner

Cambridge, MA (On-site)

$172K/yr – $233K/yrSenior Level8+ years expFull time

Posted 4 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the CRM platform roadmap and day-to-day delivery across Commercial and Medical stakeholders, with a strong eye on governance, data quality, and compliance to drive field productivity and engagement.

Own day-to-day CRM product management including backlog, user stories, release planning, and adoption.
Coordinate cross-functional stakeholders (Commercial, Medical Affairs, Omnichannel, Data, IT) to ensure priorities drive measurable value and smooth adoption.
Shape governance and platform operations with vendors and internal teams to sustain a scalable, compliant CRM ecosystem.

Job Description

Responsibilities

Define and Manage the CRM Roadmap: Develop and maintain a clear, prioritized CRM product roadmap aligned to Commercial, Medical, and enterprise technology priorities. Translate business objectives into practical platform capabilities that improve field productivity, customer engagement, compliance, and data quality.
Support CRM Modernization: Partner with IT and business leadership to evaluate and plan future CRM capabilities, including the evolution of current Veeva CRM capabilities and potential next-generation CRM platforms. Bring product, process, and platform insight to help shape a modern, scalable CRM ecosystem.
Lead Product Ownership and Delivery: Own day-to-day product management for CRM capabilities, including intake, requirements, prioritization, backlog management, delivery coordination, release planning, and adoption. Translate business needs into user stories and acceptance criteria that enable effective delivery by internal teams and external partners.
Partner with Stakeholders and Drive Adoption: Serve as a key liaison between Commercial, Medical Affairs, Omnichannel, Data, and IT teams. Understand business processes and pain points, align stakeholders on priorities, communicate progress, and support change management to ensure new capabilities are adopted and deliver measurable value.
Oversee Platform Operations and Vendor Delivery: Ensure the CRM ecosystem is reliable, well-supported, and continuously improved. Coordinate platform administration, managed services, vendor delivery, support processes, data quality, and issue resolution in partnership with internal teams and external providers.
Measure Value and Performance: Prioritize enhancements based on business value, risk, effort, and strategic alignment. Define success measures, monitor adoption and usage, and use performance data to refine priorities and communicate impact to leadership.
Maintain Governance, Privacy, and Compliance: Embed governance, privacy, promotional compliance, and quality considerations into CRM delivery. Partner with Legal, Privacy, Compliance, Quality, and business teams to ensure CRM processes and documentation remain aligned with company policies and life sciences requirements.
Identify Opportunities for Continuous Improvement: Stay current on CRM trends, life sciences platform capabilities, analytics, automation, and AI-enabled opportunities. Bring forward practical recommendations that improve user experience, operational efficiency, and customer engagement outcomes.

Alnylam Pharmaceuticals

3.5 Glassdoor

SILENCE DISEASE. AMPLIFY LIFE.TMAlnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.See our social media community guidelines: https://bit.ly/2FcRhJy.Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861Fraudulent Recruitment ActivityBe aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Founded in 2002

Cambridge, Massachusetts, USA

2.7K employees (134 in marketing)

www.alnylam.com

62% recommend to a friend

83% CEO approval